Taysha Gene Therapies, Inc. (TSHA)

NASDAQ: TSHA · Real-Time Price · USD

2.470

+0.290 (13.30%)

At close: Nov 22, 2024, 4:00 PM

2.427

-0.043 (-1.76%)

After-hours: Nov 22, 2024, 6:54 PM EST

Taysha Gene Therapies Employees

Taysha Gene Therapies had 52 employees as of December 31, 2023. The number of employees decreased by 13 or -20.00% compared to the previous year.

Employees

52

Change (1Y)

-13

Growth (1Y)

-20.00%

Revenue / Employee

$190,673

Profits / Employee

-$437,923

Market Cap

506.21M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	52	-13	-20.00%
Dec 31, 2022	65	-113	-63.48%
Dec 31, 2021	178	140	368.42%
Dec 31, 2020	38	-	-

Related Stocks

Company Name	Employees
DocGo	4,164
Quanterix	441
National Research	435
Allogene Therapeutics	233
Rigel Pharmaceuticals	147
Tango Therapeutics	140
Foghorn Therapeutics	116
Korro Bio	102

Employee Rankings

TSHA News

8 days ago - Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
9 days ago - Taysha Gene Therapies, Inc. (TSHA) Q3 2024 Earnings Call Transcript - Seeking Alpha
9 days ago - Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
21 days ago - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
4 weeks ago - Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress - GlobeNewsWire
5 weeks ago - Taysha Gene Therapies: Unjustified Sell-Off - Enough Cash Runway And Promising Rett Syndrome Data - Seeking Alpha
3 months ago - Taysha Gene Therapies, Inc. (TSHA) Q2 2024 Earnings Call Transcript - Seeking Alpha
3 months ago - Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire